A little on Onco-VAX vaccine for Stage II CRC (plus two new):
Some interesting trials:TAS-102
medicalxpress.com/news/2012-08-drug-trial-patients-advanced-colorectal.html
and avastin,temsirolimus and liposomal doxorubicin:
clincancerres.aacrjournals.org/content/early/2012/08/25/1078-0432.CCR-12-1158.abstract
Comments
-
future vaccines for CRC patients based on individual genetics
Awesome news about the future vaccine for Stage 2 CRC patients. This is the same company that has the test out since 2010 for Stage 2 diagnosed patients that predicts risk of recurrence or effectiveness of chemo based on individual tumor genetics, isn't it?
K10 -
Wowk1 said:future vaccines for CRC patients based on individual genetics
Awesome news about the future vaccine for Stage 2 CRC patients. This is the same company that has the test out since 2010 for Stage 2 diagnosed patients that predicts risk of recurrence or effectiveness of chemo based on individual tumor genetics, isn't it?
K1
This is very interesting as my hubby is stage 2a. I wonder what it means exactly?0 -
Don't know if this is still available from Nov,2010:k1 said:future vaccines for CRC patients based on individual genetics
Awesome news about the future vaccine for Stage 2 CRC patients. This is the same company that has the test out since 2010 for Stage 2 diagnosed patients that predicts risk of recurrence or effectiveness of chemo based on individual tumor genetics, isn't it?
K1
"Study uses the patient's tumor to form vaccine" at:physorg.com/print209816809.html
(Also,a biopsy from one part of a tumor may show different makeup than another section......)
Here's a report from Jan,2012 from a German trial:fiercebiotech.com/print/node/2970850 -
A little more on TAS-102:coloCan said:Don't know if this is still available from Nov,2010:
"Study uses the patient's tumor to form vaccine" at:physorg.com/print209816809.html
(Also,a biopsy from one part of a tumor may show different makeup than another section......)
Here's a report from Jan,2012 from a German trial:fiercebiotech.com/print/node/297085
medpagetoday.com/HematologyOncology/ColonCancer/34443
(Reolysin with Folfiri is also in trial)0 -
TAS 102/OncoVax
This looks interesting and would e interested to hear from anyone who is entering the new trial- tehre is a 800 patient international Phase 3 trial starting soon to look at TAS102 in people with refractory colorectal cancers. The Phase 2 trial was very (almost too) positive with increased tumour stability and survival- the results are more inpressive than the phase 2 trials in regorafenib and aflibercept- so good phase 3 results may lead to licensing failry quickly.
Oncovax sounds interesting though seems a little unproven. It is interesting that they are going for FDA approval after only phase 2 trials so will be interesting to see if they get it. AGain the results sound a little too good to be true and there are many drugs that show great results at phase 2 and never make it to market as phase 3 trials (bigger, more robust and controlled trials) don't show similar results.
Overall great to hear of lots of possible good developments but important not to get over excited about things that sound good in the media but are a fair way off being used widely.
steve0 -
TAS 102/OncoVax
This looks interesting and would e interested to hear from anyone who is entering the new trial- tehre is a 800 patient international Phase 3 trial starting soon to look at TAS102 in people with refractory colorectal cancers. The Phase 2 trial was very (almost too) positive with increased tumour stability and survival- the results are more inpressive than the phase 2 trials in regorafenib and aflibercept- so good phase 3 results may lead to licensing failry quickly.
Oncovax sounds interesting though seems a little unproven. It is interesting that they are going for FDA approval after only phase 2 trials so will be interesting to see if they get it. AGain the results sound a little too good to be true and there are many drugs that show great results at phase 2 and never make it to market as phase 3 trials (bigger, more robust and controlled trials) don't show similar results.
Overall great to hear of lots of possible good developments but important not to get over excited about things that sound good in the media but are a fair way off being used widely.
steve0 -
I'm not able to read this onsteved said:TAS 102/OncoVax
This looks interesting and would e interested to hear from anyone who is entering the new trial- tehre is a 800 patient international Phase 3 trial starting soon to look at TAS102 in people with refractory colorectal cancers. The Phase 2 trial was very (almost too) positive with increased tumour stability and survival- the results are more inpressive than the phase 2 trials in regorafenib and aflibercept- so good phase 3 results may lead to licensing failry quickly.
Oncovax sounds interesting though seems a little unproven. It is interesting that they are going for FDA approval after only phase 2 trials so will be interesting to see if they get it. AGain the results sound a little too good to be true and there are many drugs that show great results at phase 2 and never make it to market as phase 3 trials (bigger, more robust and controlled trials) don't show similar results.
Overall great to hear of lots of possible good developments but important not to get over excited about things that sound good in the media but are a fair way off being used widely.
steve
I'm not able to read about this on my phone.
Question - Does this have to be given with another chemo.....like irinotecan, folfox, of folfuri......i hope not. Too many people ran the course on first and second lines. It would be so wonderfulllllllllll to have something new without having to mix it in with the old regimens.
Thanks.0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 396 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.3K Kidney Cancer
- 670 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 537 Sarcoma
- 730 Skin Cancer
- 652 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards